Doxapram Administration on Diaphragmatic Excursion in Mechanically Ventilated Patients With Chronic Obstructive Pulmonary Disease Undergoing Spontaneous Breathing Trial

ConditionsCOPD Mechanical Ventilation Weaning From Mechanical Ventilation

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age20-65

SponsorCairo University

About this trial

Researchers aim to evaluate the impact of doxapram administration on diaphragmatic excursion in chronic obstructive pulmonary disease (COPD) patients undergoing spontaneous breathing trial

Eligibility criteria

Qualifiers

Patients with moderate to severe chronic obstructive pulmonary disease undergoing spontaneous breathing trial

Disqualifiers

Refusal Allergy to doxapram neuromuscular disorders inability to evaluate the diaphragm

Trial design

Treatments tested in this trial

Doxapram

Treatment groups

35 Participants

are divided into 1 treatment group

Sponsors and collaborators

Cairo University

Lead sponsor

Source ClinicalTrials.gov